These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26386941)

  • 41. Efficacy and safety of a calcium sensitizer, levosimendan, in patients with right heart failure due to pulmonary hypertension.
    Jiang R; Zhao QH; Wu WH; Zhang R; Yuan P; Gong SG; He J; Luo CJ; Qiu HL; Wang L; Liu JM
    Clin Respir J; 2018 Apr; 12(4):1518-1525. PubMed ID: 28862394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levosimendan produces an additional clinical and hemodynamic benefit in patients with decompensated heart failure successfully submitted to a fluid removal treatment.
    Giglioli C; Cecchi E; Landi D; Chiostri M; Spini V; Valente S; Gensini GF; Romano SM
    Congest Heart Fail; 2012; 18(1):47-53. PubMed ID: 22277178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.
    Packer M; Colucci W; Fisher L; Massie BM; Teerlink JR; Young J; Padley RJ; Thakkar R; Delgado-Herrera L; Salon J; Garratt C; Huang B; Sarapohja T;
    JACC Heart Fail; 2013 Apr; 1(2):103-11. PubMed ID: 24621834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
    Comín-Colet J; Manito N; Segovia-Cubero J; Delgado J; García Pinilla JM; Almenar L; Crespo-Leiro MG; Sionis A; Blasco T; Pascual-Figal D; Gonzalez-Vilchez F; Lambert-Rodríguez JL; Grau M; Bruguera J;
    Eur J Heart Fail; 2018 Jul; 20(7):1128-1136. PubMed ID: 29405611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do levosimendan have an adverse effect on platelet function?
    Kaptan K; Beyan C; Ifran A
    Int J Cardiol; 2010 Oct; 144(3):414-5. PubMed ID: 19327852
    [No Abstract]   [Full Text] [Related]  

  • 47. Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'.
    Rafiq I; Freeman LJ
    Int J Cardiol; 2015 Sep; 195():283-4. PubMed ID: 26056958
    [No Abstract]   [Full Text] [Related]  

  • 48. Levosimendan: a retrospective single-center case series.
    Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA
    J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL; Fitzpatrick JT
    Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure.
    Papanikolaou J; Tsolaki V; Makris D; Zakynthinos E
    Int J Cardiol; 2014 Oct; 176(3):1435-7. PubMed ID: 25147072
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter?
    Yontar OC; Yilmaz MB; Yalta K; Tandoğan I
    Anadolu Kardiyol Derg; 2010 Aug; 10(4):310-6. PubMed ID: 20693125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of sustained effects of levosimendan on right ventricular systolic functions in patients with advanced heart failure.
    Mansiroglu AK; Oner E; Erturk M; Karakurt H; Somuncu MU; Birant A; Kalkan AK; Ozturk D; Eksik A
    Acta Cardiol; 2016 Aug; 71(4):411-5. PubMed ID: 27594356
    [No Abstract]   [Full Text] [Related]  

  • 53. Levosimendan and nesiritide as a combination therapy in patients with acute heart failure.
    Jia Z; Guo M; Zhang LY; Zhang YQ; Liang HQ; Song Y
    Am J Med Sci; 2015 May; 349(5):398-405. PubMed ID: 25853935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
    Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan.
    Antila S; Kivikko M; Lehtonen L; Eha J; Heikkilä A; Pohjanjousi P; Pentikäinen PJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):412-5. PubMed ID: 15025738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there a place for levosimendan in the intensive care unit?
    Delaney A; Bradford C; McCaffrey J; Bagshaw SM; Lee R
    Crit Care Resusc; 2007 Sep; 9(3):290-2. PubMed ID: 17767458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
    Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
    Follath F; Franco F; Cardoso JS
    Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of acute cardiac failure by intracoronary administration of levosimendan.
    Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
    J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term intravenous inotropes in low-output terminal heart failure?
    von Scheidt W; Pauschinger M; Ertl G
    Clin Res Cardiol; 2016 Jun; 105(6):471-81. PubMed ID: 26879807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.